I AM HERE BECAUSE I CARE DEEPLY FOR THE MESH INJURED AND THEIR FAMILY MEMBERS!

1505.80sc

Aaron Horton

Aaron Horton's activity stream


  • FDA Safety Communication: Test Results Associated with Sciex Mass Spectrometers

    http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm518830.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery


  • commented on Hernia Nightmare - Part 2: 2016-05-17 08:05:15 -0500
    Thank you for sharing your story, Barry. I know so many people will resonate with your journey. Thank you for your contribution to this community! When our community members connect with one another… that’s when real change starts to happen. With love and gratitude, Aaron
  • commented on Women and Healthcare: A History of Unequal Harm 2015-12-14 20:01:10 -0600
    Thank you for commenting Bruce. I am so terribly sorry about your suffering. Sadly, I wish experiences like these were so much less common. Just know that so many of us are trying to change things! Thank you for reading!
  • posted about Mesh News Desk Trial Coverage Cut For Being ‘Advocacy’ Organization on Facebook 2015-12-14 10:07:50 -0600
    Mesh News Desk Trial Coverage Cut For Being ‘Advocacy’ Organization

    Mesh News Desk Trial Coverage Cut For Being ‘Advocacy’ Organization

    THIS IS SUCH AN INFRINGEMENT ON THE PUBLIC'S RIGHT TO ATTEND A TRIAL, AND THE ESTABLISHED FREE PRESS OF OUR NATION! If mesh manufacturers are afraid of media coverage, then they KNOW they are guilty! 

    http://meshmedicaldevicenewsdesk.com/mesh-news-desk-shut-out-of-courtroom-for-being-advocacy-organization#comment-608120

     


  • posted about NEW RESEARCH: Degradation of polypropylene in vivo (MESH IS NOT INERT!) on Facebook 2015-10-04 19:42:26 -0500
    NEW RESEARCH: Degradation of polypropylene in vivo (MESH IS NOT INERT!)

    NEW RESEARCH: Degradation of polypropylene in vivo (MESH IS NOT INERT!)

    Degradation of polypropylene in vivo: A microscopic analysis of meshes explanted from patients 

    Published online: 8/28/15 - JOURNAL OF BIOMEDICAL MATERIALS RESEARCH

    Keywords:

    • polypropylene;
    • mesh;
    • degradation;
    • pathology;
    • microscopy;
    • hernia;
    • vaginal

    Abstract

    Polypropylene meshes, originally introduced for hernia repair, are presently utilized in several anatomical sites. Several million are implanted annually worldwide. Depending on the device, up to 10% will be excised to treat complications. The excised meshes can provide material to study the complications, however, they have remained underutilized over the last decades and the mechanisms of complications continue to be incompletely understood. The fundamental question as to whether polypropylene degrades in vivo is still debated. We have examined 164 excised meshes using conventional microscopy to search for features of polypropylene degradation. Four specimens were also examined by transmission electron microscopy. The degraded material, detected by its ability to absorb dyes in the degradation nanopores, formed a continuous layer at the surface of the mesh fibers. It retained birefringence, inclusions of non-degraded polypropylene, and showed ability to meld with the non-degraded fiber core when heated by the surgical cautery. Several features indicated that the degradation layer formed in vivo: inflammatory cells trapped within fissures, melting caused by cautery of excision surgery, and gradual but progressive growth of the degradation layer while in the body. Cracking of the degraded material indicated a contribution to clinically important mesh stiffening and deformation. Chemical products of degradation need to be analyzed and studied for their role in the mesh-body interactions. The described methods can also be used to study degradation of other materials. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2015.


  • posted about NEW MESH-RELATED RESEARCH: A retrospective review and observations over a 16-year clinical . . . on Facebook 2015-09-14 12:20:40 -0500
    NEW MESH-RELATED RESEARCH: A retrospective review and observations over a 16-year clinical . . .

    NEW MESH-RELATED RESEARCH: A retrospective review and observations over a 16-year clinical . . .

    A retrospective review and observations over a 16-year clinical experience on the surgical treatment of chronic mesh infection. What about replacing a synthetic mesh on the infected surgical field?

    http://www.ncbi.nlm.nih.gov/pubmed/24509890

    Author information

    • 1General and Trauma Surgery, Department of Surgery, School of Medicine, University of São Paulo, São Paulo, Brazil, cacobirolini@hotmail.com.

    Abstract

    PURPOSE:

    To review the short- and long-term results in patients who underwent removal of infected or exposed mesh and reconstruction of the abdominal wall with simultaneous mesh replacement.

    METHODS:

    Patients undergoing removal of an infected or exposed mesh and single-staged reconstruction of the abdominal wall with synthetic mesh replacement over a 16-year period were retrospectively reviewed from a prospectively maintained database. Patients were operated and followed by a single surgeon. Outcome measures included wound complications and hernia recurrence.

    RESULTS:

    From 1996 until 2012, 41 patients (23 F, 18 M), with a mean age of 53.4 years and mean BMI of 31.2 ± 8 kg/m(2), were treated for chronic mesh infection (CMI). A suppurative infection was present in 27 patients, and 14 had an exposed mesh. The need for recurrent incisional hernia repair was observed in 25 patients; bowel resections or other potentially contaminated procedures were associated in 15 patients. The short-term results showed an uneventful post-operative course after mesh replacement in 27 patients; 6 (14.6%) patients developed a minor wound infection and were treated with dressings and antibiotics; 5 (12%) patients had wound infections requiring debridement and one required complete mesh removal. On the long-term follow-up, there were three hernia recurrences, one of which demanded a reoperation for enterocutaneous fistula; 95% of the patients submitted to mesh replacement were considered cured of CMI after a mean follow-up of 74 months.

    CONCLUSIONS:

    CMI can be treated by removal of infected mesh; simultaneous mesh replacement prevents hernia recurrence and has an acceptable incidence of post-operative acute infection. Standard polypropylene mesh is a suitable material to be used in the infected surgical field as an onlay graft.


  • posted about NEW RESEARCH: Mesh cancer: long-term mesh infection leading to squamous-cell carcinoma on Facebook 2015-09-14 12:15:37 -0500
    NEW RESEARCH: Mesh cancer: long-term mesh infection leading to squamous-cell carcinoma

    NEW RESEARCH: Mesh cancer: long-term mesh infection leading to squamous-cell carcinoma

    Mesh cancer: long-term mesh infection leading to squamous-cell carcinoma of the abdominal wall.

    http://www.ncbi.nlm.nih.gov/pubmed/23604537

     

    Abstract

    PURPOSE:

    It is recognized that chronic inflammation can cause cancer. Even though most of the available synthetic meshes are considered non-carcinogenic, the inflammatory response to an infected mesh plays a constant aggression to the skin. Chronic mesh infection is frequently the result of misuse of mesh, and due to the challenging nature of this condition, patients usually suffer for years until the infected mesh is removed by surgical excision.

    METHODS:

    We report two cases of squamous-cell carcinoma (SCC) of the abdominal wall, arising in patients with long-term mesh infection.

    RESULTS:

    In both patients, the degeneration of mesh infection into SCC was presumably caused by the long-term inflammation secondary to infection. Patients presented with advanced SCC behaving just like the Marjolin's ulcers of burns. Radical surgical excision was the treatment of choice. The involvement of the bowel played an additional challenge in case 1, but it was possible to resect the tumor and the involved bowel and reconstruct the abdominal wall using polypropylene mesh as onlay reinforcement, in a single stage operation. He is now under adjuvant chemotherapy. The big gap in the midline after tumor resection in case 2 required mesh bridging to close the defect. The poor prognosis of case 2 who died months after the operation, and the involvement of the armpit, groin and mesenteric nodes in case 1 shows how aggressive this disease can be.

    CONCLUSION:

    Infected mesh must be treated early, by complete excision of the mesh. Long-standing mesh infection can degenerate into aggressive squamous-cell carcinoma of the skin.


  • commented on Hernia Surgery Turns Out a Nightmare!! 2015-09-08 21:41:00 -0500
    Looking forward to part B, C, D . . . write YOUR story. It is important for our community, and I hope it gives you an outlet amongst people who understand and care! You are welcome here, Barry! Thanks again!


  • posted about Find out if your doctor or hospital was paid by big pharma... and how much! on Facebook 2015-07-01 16:53:56 -0500
    Find out if your doctor or hospital was paid by big pharma... and how much!

  • posted about A HISTORY OF RECENT TRANSVAGINAL MESH VERDICTS- Have you spoken to your attorney? on Facebook 2015-06-05 11:24:49 -0500
    A HISTORY OF RECENT TRANSVAGINAL MESH VERDICTS- Have you spoken to your attorney?

    A HISTORY OF RECENT TRANSVAGINAL MESH VERDICTS- Have you spoken to your attorney?

    Transvaginal Mesh Verdicts and Settlements


    A chronology of the sixteen (16) plaintiffs’ verdicts and three (3) defense verdicts, manufacturers, products, and jurisdictions follows:
    7/12: $5.5 million – Christine Scott – C.R. Bard Avaulta Plus – CA
    2/13: $11.11 million – Linda Gross – Ethicon/JJ Prolift – NJ
    8/13: $2 million – Donna Cisson – C.R. Bard Avaulta – MDL WV
    2/14: $0 – Carolyn Lewis - Ethicon/JJ TVT-O – MDL WV
    4/14: $1.2 million – Linda Batiste – Ethicon/JJ TVT-O - TX
    7/14: $0 - Diane Albright - Boston Scientific Pinnacle – MA
    8/14: $0 – Maria Cardenas – Boston Scientific Obtryx – MA
    9/14: $3.27 million – Jo Huskey – Ethicon/JJ TVT-O – MDL WV
    9/14: $73.465 million – Martha Salazar – Boston Scientific Obtryx – TX
    11/14: $6.7+ million – Amal Eghnayem – Boston Scientific Pinnacle – MDL FL
    11/14: $6.7+ million – Margarita Dotres – Boston Scientific Pinnacle – MDL FL
    11/14: $6.7+ million – Mania Nunez – Boston Scientific Pinnacle – MDL FL
    11/14: $6.5+ million – Juana Betancourt – Boston Scientific Pinnacle – MDL FL
    11/14: $5.25 million – Jeanie Blankenship – Boston Scientific Obtryx – MDL WV
    11/14: $4.75 million – Chris Wilson – Boston Scientific Obtryx – MDL
    11/14: $4.25 million – Carol Campbell – Boston Scientific Obtryx – MDL
    11/14: $4.25 million – Jacquelyn Tyree – Boston Scientific Obtryx – MDL
    3/15: $5.7 million – Coleen Perry – Ethicon/JJ Abbrevo sling – CA
    5/15: $100 million – Deborah Barda v. Boston Scientific Pinnacle and Advantage Fit – DE
    2015 – 2016 Transvaginal Mesh Trial Schedule
    Thirty-one (31) trials against Bard/Covidien, Boston Scientific, and Ethicon in the MDLs and state courts for 2015 – 2016 follows:
    2/15: Settled – Wise v. Bard in the MDL;
    3/15: Settled - Bellew v. Ethicon (Prolift) in the MDL;
    3/15: $5.7 million – Coleen Perry – Ethicon/JJ Abbrevo sling – CA;
    5/15: Settled – Sanchez v. Boston Scientific (Pinnacle) – CA;
    5/15: $100 million – Deborah Barda v. Boston Scientific Pinnacle and Advantage Fit – DE;
    Wave 1 & 2 v. Bard (200 cases trial ready) – June 2015 in the MDL;
    Hall v. Boston Scientific – TBA 2015 in Wisconsin;
    Figueroa v. Boston Scientific – TBA 2015 in Texas;
    Ramirez v. Ethicon (TVT-O mechanically cut) – TBA in Texas;
    Wave 1 & 2 cases v. Boston Scientific (200 cases trial ready) – TBA 2015 in the MDL;
    TBA v. Boston Scientific (Solyx) – June 2015 in Texas;
    TBA v. Boston Scientific – June 2015 in Massachusetts;
    Lopez v. Boston Scientific (Solyx) – June 5, 2015 in California;
    Ramirez v. Ethicon (TVT-O, mechanically cut) – July 13, 2015 in Texas;
    Garcia v. Ethicon (TVT-S) – August 24, 2015 in Texas;
    Edwards v. Ethicon (TVT-O) – August 13, 2015 in West Virginia;
    Rabiola v Ethicon (TVT-S, Prosima) – August 24, 2015 in Texas;
    Caveness v. Ethicon – Fall 2015 in Texas;
    Cole v. Mentor OB Tape – October 19, 2015 in GA;
    Way v. Bard – October 24, 2015 in FL;
    TBA Bellwether v. Mentor OB Tape – November 30, 2015 in GA;
    Sherrer v. Boston Scientific (Solyx) and Bard (Align S) - November 30, 2015 in MO;
    TBA v. Bard (Align) – prior to December 2015 in the MDL;
    TBA v. Bard (Adjust) – prior to December 2015 in the MDL;
    Hammons v. Ethicon (Prolift) – December 7, 2015 in PA;
    Delacruz v. Ethicon (Prolift) – January 11, 2016 in PA;
    Carlino v. Ethicon (TVT) – January 25, 2016 in PA;
    Vanderveer v. Ethicon (Prolift and TVT) – February 8, 2016 in PA;
    McGee v Ethicon (TVT Secur) – February 22, 2016 in PA;
    Hansen v. Ethicon (Gynemesh PS) – March 7, 2016 in PA; and
    Navarro v. Ethicon (TVT and Pelvitex PP Mesh) – March 21, 2016 in PA.


  • posted about 20% OFF #TMWF Mesh Awareness Bracelets for Mom - Ends Tomorrow! on Facebook 2015-05-08 21:28:56 -0500
    20% OFF #TMWF Mesh Awareness Bracelets for Mom - Ends Tomorrow!

    20% OFF #TMWF Mesh Awareness Bracelets for Mom - Ends Tomorrow!

    Hello all;

    It's not too late. If you order today, you can still receive 20% OFF any color of our #TMWF Mesh Awareness Bracelets!

    Click to order from the Yes M.A.M. Market!

    These are handmade - leather, stainless steel, and glass. The bracelets are a beautiful accessory, and are also a great conversational piece for those who are mesh injured.

    With interchangeable glass buttons, one bracelet becomes two!

    Order one for someone you love today! 100% of proceeds benefit #TMWF, the only non-profit serving the mesh-injured and their family members!

    #TMWF's Mesh Injury Awareness Bracelet
    #TMWF's Mesh Injury Awareness Bracelet

  • commented on Who We Are 2015-05-08 13:24:40 -0500
    Thank you for your kind words, Rod! Each one of our board members is very significant to us and, I believe, to our community. We’ve recently added superstar, Heather Zuk! We couldn’t be more thrilled with our board members and volunteers. Thanks for noticing!
  • posted about Learn the sometimes not-so-obvious etiquette for attending any trial! on Facebook 2015-05-05 18:53:04 -0500
    Learn the sometimes not-so-obvious etiquette for attending any trial!

    Learn the sometimes not-so-obvious etiquette for attending any trial!

    A courthouse, with its grandeur and pomp and circumstance can be intimidating. Read my latest blog on some simple rules to know before you attend any trial, and you'll have the confidence to support anyone in our mesh-injured community!

    Read more here: Public Access to Mesh Trials – It’s a Constitutional Right by Aaron Leigh Horton


  • posted about 20% off our #TMWF Mesh Awareness Bracelets for Mother's Day! on Facebook 2015-05-01 22:22:57 -0500
    20% off our #TMWF Mesh Awareness Bracelets for Mother's Day!

  • posted about One Doctor, One Paragraph - What I Wish I Had Known #HAWMC on Facebook 2015-04-29 15:23:49 -0500
    One Doctor, One Paragraph - What I Wish I Had Known #HAWMC

  • posted about It's National #‎Superhero Day! Who's your FAVORITE Superhero? Mine is Professor X from X-Men! on Facebook 2015-04-28 14:58:19 -0500
    It's National #‎Superhero Day! Who's your FAVORITE Superhero? Mine is Professor X from X-Men!

    It's National #‎Superhero Day! Who's your FAVORITE Superhero? Mine is Professor X from X-Men!

    Also known as Charles Xavier, Prof. X is a Mutant rights activist, geneticist, teacher, formerly adventurer & soldier



Give Volunteer Spread the Word

connect

get updates